Clinical Trials Logo

Pharmacological Action clinical trials

View clinical trials related to Pharmacological Action.

Filter by:

NCT ID: NCT04190537 Recruiting - Clinical trials for Pharmacological Action

PARADOX - the Incidence of Paradoxical Reactions in Pediatric Patients Premedicated With Midazolam

PARADOX
Start date: September 1, 2019
Phase:
Study type: Observational

Summary The premedication is one of the essential sides of pediatrics anesthesia. Midazolam is considered such as standard these days. Children may develope a paradoxical reaction to benzodiazepines which is one of the adverse effect. Its incidence is unknown. The hypothesis is, in pediatric patients undergoing general anesthesia premedicated with oral midazolam, the incidence of the paradoxical reaction is 10%. Primary Goal of the study is to find out the incidence of the paradoxical reaction in pediatric patients premedicated with oral midazolam prior to general anesthesia. Secondary goal is to find out the incidence of the paradoxical reactions in children of different age groups. For the assessment, the study uses parameters: RASS, blood pressure, heart rate, PAED, PSAS, MAS and VAS.

NCT ID: NCT03953287 Not yet recruiting - Clinical trials for Pharmacological Action

Pharmacokinetic Study of Paracetamol.

Para1523
Start date: August 18, 2019
Phase: Phase 1
Study type: Interventional

Brief Summary: The study evaluate the absorption rate and pharmacodynamic of different formulation of paracetamol either in the form of normal tablets or a new rapid absorbable gelation capsule formulation "Paracetamol1523" by determining T-max and area under the response curve of paracetamol in blood concentration as well as from clinical effects after intake. Data is entered on data sheet in anonymous form and processed. The results are presented in anonymous form by publication and lecture. Experts are given the supplement: "The applicant's rights in a biomedical research project

NCT ID: NCT03904303 Not yet recruiting - Clinical trials for Pharmacological Action

Test of a New Gel-based Colon Cleansing Agent Compared to Moviprep

Start date: June 1, 2019
Phase: Phase 1
Study type: Interventional

Crossover study comparing Moviprep (for bowel cleansing) with a new gel-based colon cleansing agent before colonoscopy

NCT ID: NCT03714360 Completed - Clinical trials for Pharmacological Action

The Effect of Tranexamic Acid. A Randomised Study of Patients Undergoing Elective Lumbar Spine Surgery.

Start date: October 19, 2015
Phase: Phase 4
Study type: Interventional

In this randomized double blind placebo controlled study of tranexamic acid during minor spinal surgery, mean postoperative blood loss in the patients who received TXA was statistically significantly lower compared to placebo.

NCT ID: NCT03622047 Recruiting - Clinical trials for Pharmacological Action

Comparison of Epidural Labor Analgesia With Dexmedetomidine or Sufentanil

Start date: August 15, 2018
Phase: N/A
Study type: Interventional

The participants: 1800 full-term primiparas will be selected with ASA I-Ⅱgrade, 20 to 35 years old and weighing 55 to 90 kg in the investigator's hospital from may 2018 to December 2018. 1200 primiparas were divided into A and B according to the computer randomized numbers, and 600 parturients without labor analgesia in the same period were selected as group C, with 600 patients in each group. All parturients signed the informed consent form and were approved by the hospital ethics Committee.

NCT ID: NCT03522532 Completed - Clinical trials for Pharmacological Action

Dental Restorations Effect on Oxidative Status of the Gingival Crevicular Fluid

Start date: October 2016
Phase: N/A
Study type: Interventional

The goal of the study was to ascertain the influence of dental caries and teeth position as well as the type and amount of the applied dental materials (DMs) on the oxidative stress (OS) status in gingival crevicular fluid (GCF).

NCT ID: NCT03359590 Completed - Clinical trials for Pharmacological Action

Sitagliptin and the Risk for Hypoglycaemia in Type 2 Diabetes Patients

Start date: March 21, 2018
Phase: Phase 2
Study type: Interventional

Sitagliptin, through its effects on sensitizing alpha-cell sensitivity to glucose, can initiate counter-regulatory glucagon responses at higher glycemic thresholds, thus reducing the number of clinically apparent hypoglycemic episodes, and/or ameliorating the severity of hypoglycemic episodes in the case that they should occur. The endpoints have defined such that consequences of this hypothesis can be measured.

NCT ID: NCT03352622 Recruiting - Clinical trials for Pharmacological Action

Pharmacogenomic in Colombian Patients With Rheumatoid Arthritis

Start date: October 17, 2017
Phase: N/A
Study type: Interventional

The pharmacogenomics of the Colombian population with rheumatoid arthritis (RA), understood as the individual response to drugs depending on the genome of each patient, can be an explanation for the problems of effectiveness and safety that appear during the pharmacotherapeutic treatment of RA. Currently, there are limited studies on the pharmacogenomics of the Colombian population; Therefore, it is necessary to identify and classify the genetic polymorphisms characteristic of Colombian patients with RA, which influence the response of methotrexate, infliximab, etanercept, adalimumab and thus contribute to precision medicine and medical prescription according to the Specificity of the genome of each patient. This project aims to determine the association of genetic polymorphisms with the response to inhibitors of tumor necrosis factor alpha (TNFα) and methotrexate. To do this, a prospective study of cases and controls will be performed in patients in 3 hospital of Colombia with pharmacotherapeutic treatment of methotrexate, infliximab, etanercept, adalimumab, in monotherapy or combination therapy. As a result, it is expected to contribute to the performance of specific genetic tests for RA and the generation of a pharmacogenomic basis of the Colombian population with RA.

NCT ID: NCT03119454 Completed - Clinical trials for Pharmacological Action

"Corticoid-16" in Long Term When Administered Systemically in Patients in Routine Medical Practice

Start date: October 2016
Phase: N/A
Study type: Observational [Patient Registry]

Evaluation of pharmacokinetic parameters of diprospan in long term when administered systemically in patients in routine medical practice. Applied research project. Design: open-comparative prospective cohort study. Two groups of subjects: - patients who are receiving diprospan in standard therapy of their existing disease, or multiple times, but following the introduction of diprospan is planned no earlier than 28 days after the first, - control group of subjects for the study of pharmacokinetic parameters diprospan and its metabolites. Objectives of the study: to evaluate the pharmacokinetic parameters of Diprospan in the long term when administered systemically in patients in routine practice.

NCT ID: NCT02985281 Enrolling by invitation - Clinical trials for Pharmacological Action

Safety and Efficacy of Gratisovir (Sofosbuvir)- Ribavirin Therapy in Pediatric Patients

Start date: December 2016
Phase: Phase 2/Phase 3
Study type: Interventional

Evaluation of Safety and Efficacy of Gratisovir (Sofosbuvir)- Ribavirin Therapy in Egyptian Pediatric Patients With Chronic Hepatitis C Infection aged 10- 18 years old.